Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Bevespi aerosphere
Synonyms :
Class :
Anti-cholinergic, Beta 2 agonists
Dosage Forms & StrengthsÂ
Inhalation aerosolÂ
Formoterol 9mcg/ Glycopyrrolate inhaled 4.8mcg for each inhalationÂ
Chronic Obstructive Pulmonary Disease (COPD)Â
Mouth spray
Orally inhaled
twice a day
Two inhalations (Formoterol 18mcg/ Glycopyrrolate inhaled 9 mcg for each inhalation)
Do not exceed two inhalations per day
may enhance the effects of the other by pharmacodynamic synergism
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
it enhances the serum potassium levels
it enhances the serum potassium levels
it enhances the serum potassium levels
may increase the QTc interval when combined
may decrease the effect of each other by unspecified interaction mechanism
may increase the QTc interval when combined
may increase the QTc interval when combined
it diminishes the serum potassium levels
may decrease the toxic effects of each other by sedation
may decrease the toxic effects of each other by sedation
may decrease the toxic effects of each other by sedation
may decrease the toxic effects of each other by sedation
may increase the QTc interval when combined
may decrease the toxic effects of each other by sedation
may decrease the toxic effects of each other by sedation
decreases the serum potassium levels
it decreases the serum potassium levels
may increase the QTc interval when combined
may increase the QTc interval when combined
may increase the QTc interval when combined
may diminish the effects through pharmacodynamic antagonism
may enhance the effects of the other by pharmacodynamic synergism
may enhance the effects of the other by pharmacodynamic synergism
may diminish the effects through pharmacodynamic antagonism
may enhance the effects of the other by pharmacodynamic synergism
may enhance the effects of the other by pharmacodynamic synergism
Frequency defined:Â Â
1-10%Â
AnxietyÂ
InfluenzaÂ
CoughÂ
ArthralgiaÂ
Muscle spasmsÂ
Acute sinusitisÂ
Tooth abscessÂ
DizzinessÂ
VomitingÂ
Chest painÂ
Frequency not definedÂ
NauseaÂ
HyperglycemiaÂ
AgitationÂ
PalpitationsÂ
Sleep disturbanceÂ
Cardiac arrhythmiasÂ
Pregnancy consideration: Insufficient data is availableÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Patient information leafletÂ
Generic Name: Glycopyrrolate inhaled/formoterolÂ
Pronounced: glye-koe-PYE-roe-late; for-MOH-te-rolÂ
Why do we use Glycopyrrolate inhaled/formoterol?Â
It is used to treat chronic obstructive pulmonary disease, which includes emphysema and chronic bronchitisÂ